Atour Lifestyle Holdings Reports Strong 2025 Financial Results with Significant Growth in Hotel Network and Retail Business

summarizeSummary

Atour Lifestyle Holdings Ltd. announced strong 2025 financial results, with net revenues up 35.1% and net income up 27.4%, driven by significant expansion in its manachised hotel network and a 67.0% surge in retail business revenue. The company also initiated a share repurchase program and a dividend policy.

check_boxKey Events

• Strong Revenue Growth

  Net revenues increased by 35.1% to RMB 9.79 billion (US$1.40 billion) for the fiscal year ended December 31, 2025, compared to RMB 7.25 billion in 2024.

• Increased Net Income

  Net income rose by 27.4% to RMB 1.62 billion (US$231.8 million) in 2025, up from RMB 1.27 billion in 2024.

• Significant Retail Business Expansion

  Retail revenues grew by 67.0% to RMB 3.67 billion (US$524.9 million) in 2025, now accounting for 37.5% of total net revenues, demonstrating successful diversification.

• Hotel Network Expansion

  The total number of hotels in operation increased by 24.5% to 2,015 as of December 31, 2025, primarily driven by the asset-light manachised model, which grew by 25.3% to 1,996 hotels.

auto_awesomeAnalysis

Atour Lifestyle Holdings Ltd. reported robust financial performance for the fiscal year ended December 31, 2025, with net revenues increasing by 35.1% to RMB 9.79 billion and net income rising by 27.4% to RMB 1.62 billion. This strong growth was primarily fueled by the expansion of its manachised hotel network, which grew by 25.3% to 1,996 hotels, and exceptional growth in its retail business, with revenues surging by 67.0% to RMB 3.67 billion. The retail segment now constitutes a significant 37.5% of total net revenues, highlighting the success of its diversification strategy. The company also demonstrated a commitment to shareholder returns by implementing a three-year annual dividend policy to distribute no less than 50% of net income and executing a $46.0 million share repurchase program in 2025. While the company continues to navigate standard regulatory risks associated with operating in China, the overall financial health and strategic execution are positive.